Insulin Resistance Syndrome Metabolic Syndrome Syndrome X
Conditions
Interventions
Study volunteers will receive, in random order, daily 70 g of soy nuts (roasted
soybeans containing approximately 100 mg isoflavones) (soy treatment) or no
food products (control treatment) for sixt
Sponsors
Universiteit Maastricht
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Aged between 60-70 years - BMI between 20-30 kg/m2 - Fasting plasma glucose
Exclusion criteria
Exclusion criteria: - Allergy or intolerance to soy - Current smoker, or smoking cessation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At baseline, anthropometric measurements will be first performed and a fasting blood sample will be drawn. After sixteen weeks, adults have to attend two times the research facilities to perform follow-up measurements. The primary endpoint is the difference at follow-up in mean gray matter cerebral blood flow, as assessed by Arterial Spin Labeling, between the soy and control treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicable. | — |
Countries
Netherlands
Outcome results
None listed